Skip to main content
. 2016 Jul;39(4):374–382. doi: 10.1080/10790268.2015.1126449

Table 2.

Detail outlines of selected articles on SDB in SCI

Author Patient selection Patients Study parameters Definition of SDB Outcome Correlates
Short (1992) Consecutive series 22, greater than 40 > 3 mo post injury EEG, EMG, EOS Trunk strain gauges O2 sats Hypopnea is O2 > 4% drop from preceding 10 minute average 55% AHI > 5 27% AHI > 15 2 central apnea No relationship to age, time since injury, obesity, spirometry
McEvoy (1995) Regional cohort 44, C8 and above, ASIA A, B, C >6 mo post injury Home sleep studyEEG, EOG, submental EMG, body movement, nasal air flow, respiratory movement, SPO2 Hypopnea = 10 second of >50% airflow drop from baseline 30% AI ≥ 5 27.5% AHI ≥ 15 AHI related to systolic bp, diastolic bp, neck circumference, supine position
Klefbeck (1998) Consecutive series 33 C4-T1 ASIA A-D 3 C4, 12 C5, 9 C6, 5 C7, 1 C8, 2T1 Hospital sleep labO2, body movement Hypopnea is O2 > 4% drop 15% met criteria Related to ASIA level in ASIA A group only
Stockhammer (2002) Random selection 50, C3-C8 23 C3-5, 27 C6-8 40 ASIA A-B Hospital sleep lab O2, nasal thermistor, chest wall motion Hypopnea 50–90% drop airflow for 10 secApnea > 90% drop for 10 sec 48% AI ≥ 5 62% AHI ≥ 15 AHI related to age, male sex, BMI.
Berlowitz (2005) Inception cohort 30, 13 finished 52 week evaluation C4 9, C5 10, C6 2, C7 1, C8 1 ASIA 1-B 20% Hospital sleep labEEG, submental and diaphragm EMG, EOG, ECG, nasal thermistor, plethysmography, SP 02 Hypopnea defined as 50% reduced airflow or <50% airflow and >3% O2 drop Apnea defined as no airflow 60% AHI ≥ 5 by 2 weeks, then stable
LeDuc (2007) Prospective cohort 41 outpatients Home unsupervised polygrams Symptoms plus AHI Hypopnea 50% reduction in airflow or >3% drop O2 56% AHI ≥ 5 No relationship of symptoms to AHIOSA related to daytime sleepiness, BMI greater than 30 kg/m2, neck circumference and greater than 3 awakenings at night
Berlowitz (2012) Cross sectional 78, tetraplegia Hospital sleep labEEG, submental and diaphragm EMG, EOG, ECG, nasal thermistor, plethysmography, SP 02 AHI > 10 91% complete with SDB 56% incomplete No relationship between AHI and ASIA level
Sankari (2014 J Appl Physiol) Case Control 16 SCI (6 cervical) and 16 control Non-invasive hyperventilation to induce apnea, CO2 trial to abolish central apneaPolysomnogram AHI > 5 Central SDB 63% cervical, 13% thoracic CO2 reserve narrower in cervical, best in controls.
Sankari (2014 JCSM) Consecutive Series 26, 15 cervical Hospital sleep study Polysomnogram: EEG, submental EMG, nasal air flow, pharyngeal pressure, ETCO2, upper airway resistance Epworth, Pittsburgh, Berlin, Fatigue severity AHI > 5 Central AI > 5 PSQ 10.3, ESS 10.4 Fatigue 96%, daytime sleepiness 59%, Berlin high risk 46%. AHI >5 77%, 89% cervical, 50% thoracic. Central AI 33% cervical, 13% thoracic.
TREATMENT
Burns (2005) Postal survey 40 of 72 being treated for SDB CPAP tried by 80%, used by 63%. Reasons: 67% unable to fall asleep, 42% discomfort, 33% claustrophobia No difference in symptoms between users and non-users
Berkowitz (2009) Prospective cohort 74% of 19 with SCI and AHI >10 Auto-titration CPAP with PT support for 3–4 nights Patients who tolerated CPAP were older, had higher BMI, were sleepier and had more severe OSA
Leguen (2012) Retrospective Case Control 25 SCI, 219 controls with OSA No relationship between effective use and BMI or AHI